Search filters

List of works by Hans-Peter Hartung

'Bubbles in the brain': retrograde venous air embolism in the cavernous sinus

scientific article published on 28 February 2009

10 years of interferon beta-1b (Beta feron therapy

scientific article

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

scientific article published on 2 September 2009

A 69-year-old man with left hemispheric necrotizing mass lesion

scientific article published in July 2009

A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis

scientific article

A new role for interferon gamma in neural stem/precursor cell dysregulation

scientific article published on 3 March 2011

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients

scientific article

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up

scientific article published on 20 May 2015

A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

scientific article published on 30 March 2018

ADAM‐10 and ADAM‐17 in the inflamed human CNS ⬇️

scientific article published on June 1, 2003

ALEMTUZUMAB PERSISTENTLY SLOWS BRAIN VOLUME LOSS IN RRMS

scientific article published on 15 November 2016

Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7.

scientific article

Activation of CXCR7 receptor promotes oligodendroglial cell maturation ⬇️

scientific article published on December 1, 2010

Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitis

scientific article published on 14 July 2016

Activation of macrophages by neuropeptides

scientific article published on December 1988

Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis

scientific article

Acute disseminated encephalomyelitis: an acute hit against the brain

scientific article

Acute disseminated encephalomyelitis: an update

scientific article

Acute exacerbations after decades of non-active chronic multiple sclerosis

scientific article published in January 2018

Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis

scientific article published on April 1995

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis

scientific article

Advances in the understanding of the mechanism of action of IVIg

scientific article published on July 2008

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

scientific article published in August 2004

Age-dependent modulation of cortical transcriptomes in spinal cord injury and repair

scientific article

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy

scientific article

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

scientific article

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

scientific article

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

scientific article published on 12 October 2016

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

scientific article (publication date: November 2012)

Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis

scientific article

Alemtuzumab: the advantages and challenges of a novel therapy in MS.

scientific article

Ammonium chloride influences in vitro-neuronal network activity

scientific article published on 7 March 2012

An Assay to Determine Mechanisms of Rapid Autoantibody-Induced Neurotransmitter Receptor Endocytosis and Vesicular Trafficking in Autoimmune Encephalitis

An Interesting Case of Nuchal Rigidity ⬇️

scientific article published on May 1, 2011

An assay to quantify species-specific anti-JC virus antibody levels in MS patients

scientific article published on 6 February 2013

Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

scientific article published on 25 September 2009

Animal models for autoimmune demyelinating disorders of the nervous system

scientific article

Animal models of multiple sclerosis--potentials and limitations

scientific article published on 15 June 2010

Anti-JC-virus antibody prevalence in a German MS cohort

scientific article

Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.

scientific article

Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo

scientific article published in April 1996

Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2

scientific article

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis

scientific article published in September 2001

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

scientific article

Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro

scientific article published on May 1997

Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy

scientific article published on 10 May 2017

Are statins a treatment option for multiple sclerosis?

scientific article published on June 2004

Assessment of JC virus DNA in blood and urine from natalizumab‐treated patients ⬇️

scientific article published on January 1, 2011

Assessment of microRNA-related SNP effects in the 3′ untranslated region of the IL22RA2 risk locus in multiple sclerosis

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

scientific article

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

scientific article

Atacicept: targeting B cells in multiple sclerosis ⬇️

scientific article published on July 1, 2010

Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome

scientific article published in February 2010

Autoimmunity in the peripheral nervous system

scientific article published on January 2003

Autoimmunity in the peripheral nervous system.

scientific article

Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review

scientific article

Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder?

scientific article published in June 2002

Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials.

scientific article

Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis

scientific article published on 13 September 2017

Bilateral medullary pyramid infarction

scientific article published in May 2005

Bimanual recoupling by visual cueing in callosal disconnection

scientific article published in August 2004

Biologic role of interferon beta in multiple sclerosis

scientific article published in June 2004

Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards

scientific article published on 21 June 2013

Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization

scientific article published in February 2004

Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope

scientific article

Brachial amyotrophic diparesis associated with anti-Hu positive anterior horn cell disease and autonomic disorder ⬇️

scientific article published on November 8, 2012

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study

scientific article published on 30 January 2018

CD19 as a molecular target in CNS autoimmunity

scientific article

CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus

scientific article published on 15 November 2010

CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction

scientific article published on October 2003

CIDP and isolated osteosclerotic myeloma

scientific article published in December 2004

CIDP and other inflammatory neuropathies in diabetes - diagnosis and management

scientific article published on 15 September 2017

CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation

scientific article published on 7 January 2016

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

scientific article

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies ⬇️

scientific article published on July 17, 2012

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

scientific article

Cerebrospinal fluid biomarkers in multiple sclerosis

scientific article published on 05 May 2009

Cerebrospinal fluid of brain trauma patients inhibits in vitro neuronal network function via NMDA receptors

scientific article published in October 2009

Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design

scientific article published on 7 August 2011

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions

scientific article

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

scientific article published in April 2002

Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis

scientific article published in January 2001

Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis, diagnostic criteria and therapy

scientific article

Chronic inflammatory demyelinating polyneuropathy.

scientific article

Chronic inflammatory polyneuritis and neuropathies

scientific article published on June 1996

Circulating adhesion molecules and inflammatory mediators in demyelination: a review

scientific article published on June 1995

Cladribine as a therapeutic option in multiple sclerosis ⬇️

scientific article published on June 1, 2011

Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis

scientific article

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

scientific article

Cloning and expression of theCampylobacter jejuni longene detected by RNA arbitrarily primed PCR ⬇️

scientific article published on August 15, 1998

Cloning, sequencing and molecular analysis of the Campylobacter jejuni groESL bicistronic operon

scientific article published on January 1999

Closing the case ofAPOEin multiple sclerosis: no association with disease risk in over 29 000 subjects: Figure 1

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study ⬇️

scientific article published on May 13, 2011

Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy

scientific article

Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome

scientific article published on 22 February 2017

Correlating immunological and magnetic resonance imaging markers of disease activity in multiple sclerosis

scientific article published on May 1, 1998

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis ⬇️

scientific article published on April 27, 2012

Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors

scientific article published on June 1996

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

scientific article

Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease

scientific article published on 25 February 2014

Current disease-modifying therapies in multiple sclerosis

scientific article

Cyclo-oxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve

scientific article published in December 2003

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab

scientific article

Despair of repair

scientific article published in January 2002

Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta

scientific article published on 6 July 2017

Development and pharmacological modulation of embryonic stem cell-derived neuronal network activity

scientific article

Development of oral cladribine for the treatment of multiple sclerosis

scientific article

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

scientific article published on 21 December 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

scientific article

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases

scientific article

Differential expression of matrix metalloproteinases in bacterial meningitis

scientific article

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

scientific article

Disease-modifying agents for multiple sclerosis: recent advances and future prospects

scientific article published on January 2008

Disease-modifying therapies and infectious risks in multiple sclerosis

scientific article published on 4 March 2016

Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis

scientific article published on 19 May 2020

Dose-dependent inhibition of demyelination and microglia activation by IVIG.

scientific article published on 23 September 2016

Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

scientific article published on 18 December 2017

Drug Treatment of Clinically Isolated Syndrome

scientific article published on 01 July 2019

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

scientific article

Early treatment and dose optimisation BENEFIT and BEYOND.

scientific article

Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study

scientific article published on January 1, 1995

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

scientific article published in March 2018

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

scientific article

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

scientific article

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

scientific article

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial

scientific article published on 4 February 2014

Effector mechanisms in demyelinating neuropathies.

scientific article published on May 1996

Effector pathways in immune mediated central nervous system demyelination

scientific article

Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis

scientific article published on 08 February 2020

Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome

scientific article

Effects of ganglioside administration on experimental autoimmune neuritis induced by peripheral nerve myelin or P2-specific T cell lines ⬇️

scientific article published on March 1, 1993

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

scientific article published on 4 April 2012

Electrophysiologic correlations with clinical outcomes in CIDP ⬇️

scientific article published on October 1, 2010

Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.

scientific article published in April 2009

Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod ⬇️

scientific article published on November 1, 2012

Encephalo-myelo-radiculo-ganglionitis presenting as pandysautonomia

scientific article published in May 1991

Enhancing remyelination in disease--can we wrap it up? ⬇️

scientific article published on April 19, 2011

Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles

scientific article published on January 2005

Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis

scientific article published on May 2007

Evidence for use of glatiramer acetate in multiple sclerosis

scientific article

Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy

scientific article

Experimental allergic neuritis and Guillain-Barré syndrome: immune mechanisms. A short review.

scientific article published on January 1994

Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies

scientific article

Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome

scientific article published on October 1998

Expression of specific matrix metalloproteinases in inflammatory myopathies

scientific article published in February 2001

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica ⬇️

scientific article published on February 1, 2012

Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system.

scientific article published in June 2016

Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy ⬇️

scientific article published on May 26, 2011

Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype

scientific article published on 7 May 2015

Fingolimod is a potential novel therapy for multiple sclerosis

scientific article published on 15 June 2010

Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling

scientific article published on 10 June 2016

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse

scientific article

Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure in suspected therapeutic failure

scientific article published in December 1997

FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies

scientific article

From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve

scientific article published on April 2007

Fulminant intramedullary spinal cord sarcoidosis

scientific article published on 13 September 2017

GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study

scientific article

Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage ("Neuroprotection").

scientific article published on April 2015

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

scientific article

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

scientific article

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.

scientific article published on 12 January 2013

Genome-wide significant association with seven novel multiple sclerosis risk loci

scientific article

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

scientific article

Guillain-Barré syndrome after exposure to influenza virus ⬇️

scientific article published on September 1, 2010

Guillain–Barré Syndrome

scientific article

HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis

scientific article published on 24 July 2008

HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis

scientific article published on 3 October 2008

High throughput analysis of TCR-beta rearrangement and gene expression in single T cells

scientific article published in March 2006

Histone methyltransferase enhancer of zeste homolog 2 regulates Schwann cell differentiation

scientific journal article

Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds

scientific article published in April 1999

Human Endogenous Retroviruses in Neurological Diseases

scientific article published on 15 March 2018

Human T lymphocytes distinguish bovine from human P2 peripheral myelin protein: implications for immunological studies on inflammatory demyelinating neuropathies

scientific article published on June 1994

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation

scientific article published on 16 September 2013

Human mesenchymal factors induce rat hippocampal- and human neural stem cell dependent oligodendrogenesis

scientific article

Humoral immune responses after rabies infection.

scientific article published in September 2007

IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties

scientific article

Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. ⬇️

scholarly article

Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine

scientific article

Immune circuitry in the peripheral nervous system

scientific article published on October 2006

Immune mechanisms in acute and chronic inflammatory polyneuropathies

scientific article published on December 1988

Immune mechanisms in chronic inflammatory demyelinating neuropathy

scientific article

Immune mechanisms in inflammatory polyneuropathy

scientific article published on January 1988

Immune regulation of multiple sclerosis

scientific article published on January 2014

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis

scientific article

Immune-mediated demyelination

scientific article

Immune-mediated neuropathies

scientific article published on 11 October 2018

Immune-mediated neuropathies.

scientific article

Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth

scientific article published on 29 May 2015

Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS.

scientific article published on May 1997

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

scientific article

Immunopathogenesis and immunotherapy of multiple sclerosis

scientific article published on April 2006

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

scientific article published on February 1995

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II.

scientific article published on February 1995

Immunopathogenesis of multiple sclerosis: the role of T cells

scientific article

Immunosuppressive agents in multiple sclerosis

scientific article published on October 2007

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

scientific article published on June 2017

Impact of HMG-CoA reductase inhibition on brain pathology

scientific article published on 15 June 2007

In vitro neuronal network activity in NMDA receptor encephalitis

scientific article

In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema

scientific article published in February 1996

Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial

scientific article published on 13 May 2016

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

scientific article published in December 1996

Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice

scientific article published on 24 April 2006

Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample.

scientific article

Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.

scientific article published in March 1983

Infections and the Guillain-Barré syndrome

scientific article published in March 1999

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

scientific article published on 24 November 2017

Inflammatory Demyelinating Brain Lesions Heralding Primary CNS Lymphoma ⬇️

scientific article published on January 1, 2012

Inflammatory mediators in demyelinating disorders of the CNS and PNS

scientific article published on October 1, 1992

Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis

scientific article published in November 2006

Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta ⬇️

scientific article published on September 1, 2010

Inhibition of cytokine-inducible nitric oxide synthase in rat microglia and murine macrophages by methyl-2,5-dihydroxycinnamate

scientific article published on July 1996

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

scientific article published in August 1993

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia

scientific article published on 31 October 2014

Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy

scientific article published on 24 October 2016

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis

scientific article published on December 2016

Interferon Gamma and Sonic Hedgehog Signaling Are Required to Dysregulate Murine Neural Stem/Precursor Cells ⬇️

scientific article published on August 29, 2012

Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression

scientific article published in April 2001

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

scientific article published on 10 July 2013

Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies

scientific article published on 25 October 2006

Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab

scientific article

Interleukin 17F level and interferon β response in patients with multiple sclerosis

scientific article

Interleukin 23 in acute inflammatory demyelination of the peripheral nerve

scientific article published in June 2006

Interleukin-17 impedes Schwann cell-mediated myelination

scientific article published on 29 March 2014

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

scientific article published on 12 April 2017

Intravenous immunoglobulin treatment of neurological autoimmune diseases ⬇️

scientific article published on January 8, 1998

Intravenous immunoglobulins in the treatment of immune neuropathies

scientific article published on October 2008

Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.

scientific article

Is It Too Early to Predict the Failure of Natalizumab in NMO?—Reply

Isolation and characterization of an oligodendrocyte precursor–derived B‐cell epitope in multiple sclerosis ⬇️

scientific article published on January 1, 1998

Kleine-Levin syndrome. The provocation of manic symptoms by an antidepressant and a therapeutic trial of carbamazepine

scientific article published in October 1989

Lack of association between antimyelin antibodies and progression to multiple sclerosis

scientific article

Lesion pathology predicts response to plasma exchange in secondary progressive MS.

scientific article published in October 2006

Leukotriene C4 (LTC4) elicits a respiratory burst in peritoneal macrophages ⬇️

scientific article published on July 15, 1983

Leukotriene production by cultured astroglial cells

scientific article

Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis

scientific article published on June 1993

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

scientific article published on 25 June 2015

Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis

scientific article published in February 2009

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

scientific article published on July 2015

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

scientific article

Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study

scientific article published on 04 January 2019

Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis

scientific article published in February 2003

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele

scientific article published in January 2003

MANAGEMENT OF ADVERSE REACTIONS TO ALEMTUZUMAB INFUSION

scientific article published on 14 October 2015

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

scientific article published on June 2013

MRI evidence of past cerebral microbleeds in a healthy elderly population

scientific article published in March 1999

MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study

scientific article published on July 1999

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study

scientific article

Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies

scientific article published in March 1998

Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke

scientific article published on 7 July 2015

Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats

scientific article published on May 1995

Macrophages prevent hemorrhagic infarct transformation in murine stroke models

scientific article published on June 2012

Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results

scientific article published on September 2007

Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis

scientific article published on July 1993

Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study

scientific article published in November 2009

Managing Risks with Immune Therapies in Multiple Sclerosis

scientific article published on 01 May 2019

Managing the risks of immunosuppression ⬇️

scientific article published on June 1, 2011

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis ⬇️

scientific article published on January 1, 1998

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

scientific article

Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals

scientific article published in October 1993

Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis

scientific article

Mechanisms of immune regulation in the peripheral nervous system.

scientific article

Mechanisms of mitoxantrone in multiple sclerosis--what is known?

scientific article published in August 2004

Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation

scientific article

Mitoxantrone (Novantrone) in multiple sclerosis: new insights

scientific article

Mitoxantrone in multiple sclerosis.

scientific article

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

scientific article

Modulation of EAE by vaccination with T cell receptor peptides: V beta 8 T cell receptor peptide-specific CD4+ lymphocytes lack direct immunoregulatory activity

scientific article published on June 1993

Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis. A central role for TNF-alpha ⬇️

scientific article published on November 1, 1997

Molecular mechanisms of microglial activation

scientific article published on January 1996

Monoclonal Antibodies for Multiple Sclerosis: An Update

scientific article published on 01 February 2019

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

scientific article

Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation

article

Multiple paradigm shifts in multiple sclerosis

scientific article

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro

scientific article published in November 2005

Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy

scientific article

Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases

scientific article

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody

scientific article published on 3 October 2017

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis

scientific article published on 18 September 2013

Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors

scientific article

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

scientific article published on August 2010

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

scientific article

Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b

scientific article

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

scientific article

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

scientific article (publication date: August 2011)

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy

scientific article published on July 2010

Neural precursor cells as a novel target for interferon-beta

scientific article

Neurofilament ELISA validation.

scientific article published on 24 October 2009

Neuroimmunology: Assessing the value of plasma exchange in neurology

scientific article published on 3 May 2011

Neuromuscular manifestations of HIV-1 and HTLV-I infections

scientific article published in December 1988

Neuromyelitis optica following human papillomavirus vaccination

scientific article published on 20 June 2012

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

scientific article

Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System.

scientific article published in November 2015

Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis

scientific article published on 04 January 2010

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial

scientific article published on 27 September 2011

New concepts in the immunopathogenesis of multiple sclerosis

scientific article

New immunopathologic insights into multiple sclerosis ⬇️

scientific article published on May 1, 2003

Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populations

scientific article published on 6 August 2009

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

scientific article

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

scientific article published in January 2018

Novel therapeutic options for multiple sclerosis

scientific article published on 10 December 2013

Novel treatment for immune neuropathies on the horizon ⬇️

scientific article published on June 1, 2011

Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis

scientific article

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS

scientific article published on 04 June 2020

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on 21 December 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

scientific article published on 21 December 2016

Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions

scientific article published on 5 July 2013

Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives

scientific article published on 31 March 2016

Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension

scientific article published on 5 June 2017

Optical coherence tomography in parkinsonian syndromes

scientific article

Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis.

scientific article

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide

scientific article published on 9 May 2016

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

scientific article published on 09 July 2018

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

scientific article

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

scientific article

Osteopontin, a macrophage-derived matricellular glycoprotein, inhibits axon outgrowth

scientific journal article

Outcome and Treatment Effects in Stroke Associated with Acute Cervical ICA Occlusion

scientific article

PML: The Dark Side of Immunotherapy in Multiple Sclerosis

scientific article published on 20 October 2015

Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies

scientific article published in September 1996

Pathogenesis of immune-mediated demyelination in the CNS.

scientific article published on January 1997

Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study

scientific article published on 23 September 2019

Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination

scientific article

Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

scientific article

Peripheral Nerve Study Group, in Boppard, Germany, July 29th to August 1, 1993.

scientific article

Peripheral facial palsy: etiology, diagnosis and treatment

scientific article

Peripheral neuropathy: assessment of proximal nerve integrity by diffusion tensor imaging

scientific article

Persistence of immunopathological and radiological traits in multiple sclerosis

scientific article published in November 2008

Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome

scientific article

Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis

scientific article published on 27 March 2007

Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

scientific article

Pharmacological treatment of early multiple sclerosis

scientific article published on January 2008

Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation

scientific article

Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytes

scientific article published in August 1987

Placebo-controlled study in neuromyelitis optica-Ethical and design considerations

scientific article published on 14 December 2015

Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies ⬇️

scientific article published on November 5, 2010

Plasma exchange in immune-mediated neuropathies

scientific article published on October 2008

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

scientific article published on July 2006

Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders

scientific article published on August 2006

Plasmapheresis in chronic demyelinating polyneuropathy

scientific article

Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders

scientific article published on 21 June 2013

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions

scientific article published on February 2007

Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study

scientific article published in October 1997

Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis

scientific article

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

scientific article

Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017.

scientific article published in May 2017

Principles of a new treatment algorithm in multiple sclerosis

scientific article published on March 2011

Prion proteins: physiological functions and role in neurological disorders

scientific article published on 17 August 2007

Production and characterization of monoclonal antibodies to the extracellular domain of P0.

scientific article

Production of prostanoids by Lewis rat Schwann cells in vitro

scientific article

Progress in Recognizing and Treating Polyneuropathy.

scientific article

Prominent T-Cell Responses against the Acetylcholine Receptor Subunit in Myasthenia Gravis

article

Promoting myelination in an in vitro mouse model of the peripheral nervous system: the effect of wine ingredients [corrected]

scientific article (publication date: 2013)

Propentofylline and Iloprost Suppress the Production of TNF-αby Macrophages but Fail to Ameliorate Experimental Autoimmune Encephalomyelitis in Lewis Rats ⬇️

scientific article published on December 1, 1997

Pseudomonas aeruginosa and Its Bacterial Components Influence the Cytokine Response in Thymocytes and Splenocytes

scientific article published on 22 February 2016

Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis

scientific article

Pushing Forward: Remyelination as the New Frontier in CNS Diseases

scientific article published on 7 March 2016

Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate

scientific article

Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.

scientific article

Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules

scientific article

Rat astrocytes express interferon-gamma immunoreactivity in normal optic nerve and after nerve transection

scientific article published in May 1990

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis

scientific article (publication date: 2011)

Recent achievements in stem cell-mediated myelin repair

scientific article published on 31 March 2016

Recent developments and future directions in Guillain-Barré syndrome

scientific article published on December 2012

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

scientific article

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

scientific article

Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases

scientific article published on 23 June 2016

Redox-regulated fate of neural stem progenitor cells

scientific article published on 07 February 2015

Regional variation of Guillain-Barré syndrome

scientific article published on 01 October 2018

Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis

scientific article published on March 1986

Remyelinating strategies for the treatment of multiple sclerosis

scientific article

Repair strategies for multiple sclerosis: challenges, achievements and perspectives

scientific article published on 31 March 2016

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

scientific article published on 01 March 2019

Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond

scientific article published on 01 July 2018

Restoring neuronal function after stroke by cell replacement: anatomic and functional considerations

scientific article published on 07 July 2011

Retinal Neurodegeneration in Wilson’s Disease Revealed by Spectral Domain Optical Coherence Tomography ⬇️

scientific article published on November 16, 2012

Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography

scientific article published on 25 July 2012

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome

scientific article

Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography

scientific article published on 22 July 2015

Retinal pathology in idiopathic moyamoya angiopathy detected by optical coherence tomography

scientific article published on 15 July 2015

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients

scientific article published on 15 September 2017

Review of teriflunomide and its potential in the treatment of multiple sclerosis

scientific article published on 10 June 2009

Review: Pathogenesis and treatment of immune-mediated neuropathies ⬇️

scientific article published on July 1, 2009

Risk evaluation and monitoring in multiple sclerosis therapeutics

scientific article

Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany

scientific article

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity

scientific article

Role of integrins in the peripheral nervous system

scientific article

Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies

scientific article published in April 2007

Role of the leukocyte-adhesion molecule L-selectin in experimental autoimmune encephalomyelitis

scientific article published in August 1998

Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy

scientific article published on January 1990

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

scientific article published on 05 July 2016

Safety and Tolerability of Immune Globulin Intravenous in Chronic Inflammatory Demyelinating Polyradiculoneuropathy ⬇️

scientific article published on September 1, 2010

Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke

scientific article published on 27 December 2017

Secondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in mice

scientific article published in November 2012

Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis

scientific article published in July 1991

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

scientific article published on 30 March 2005

Side Effects of High-Dose Intravenous Immunoglobulins ⬇️

scientific article published on October 1, 1997

Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood ⬇️

scientific article published on September 8, 2011

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

scientific article published on 11 June 2013

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

scientific article published on 26 May 2017

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

scientific article published in October 2002

Statins as potential therapeutic agents in multiple sclerosis

scientific article published on May 2004

Statins--a cure-all for the brain?

scientific article

Steering through complexity: management approaches in multiple sclerosis

scientific article published on 7 April 2016

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 6 November 2017

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

scientific article published on 25 July 2016

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

scientific article

Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism.

scientific article

Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes

scientific article published in January 1988

Substance P, the immune system and inflammation

scientific article published on June 1989

Substance P: binding properties and studies on cellular responses in guinea pig macrophages.

scientific article

Subtle retinal pathology in amyotrophic lateral sclerosis

scientific article published on 11 March 2014

Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.

scientific article published on 02 September 2016

Suppression of actively induced and passively transferred experimental allergic neuritis by cyclosporin A.

scientific article published in January 1991

Suppression of experimental autoimmune neuritis by leflunomide

scientific article published in September 2001

Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics

scientific article published on 24 September 2014

Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management

scientific article published on 21 January 2018

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

scientific article published on 29 May 2015

Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity ⬇️

scientific article published on September 1, 2012

T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors

scientific article published in February 1990

T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies

scientific article

T lymphocyte recognition sites on peripheral nerve myelin P0 protein ⬇️

scientific article published on October 1, 1994

T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome

scientific article published on January 1990

T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms

scientific article published on September 1997

T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection

scientific article published in January 1999

T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease ⬇️

scientific article published on June 20, 1995

Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.

scientific article published on 2 October 2015

Targeting two-pore domain potassium channels - a promising strategy for treating T cell mediated autoimmunity

scientific article published on 23 January 2013

Temporary leukocyte effects in temporal lobe epilepsy?

scientific article published on 23 April 2008

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

scientific article published on 10 August 2016

The ClpB protein from Campylobacter jejuni: molecular characterization of the encoding gene and antigenicity of the recombinant protein

scientific article published in April 1999

The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis

scientific article

The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines

scientific article

The blood-nerve barrier in Wallerian degeneration: a sequential long-term study

scientific article

The complex world of oligodendroglial differentiation inhibitors

scientific article published on April 2011

The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study

scientific article published on 9 October 2017

The future of multiple sclerosis therapy

scientific article

The immunocompetence of Schwann cells

scientific article published on January 2008

The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome.

scientific article published on June 1996

The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy

scientific article

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

scientific article

The monoclonal antibody 23E9 defines a novel developmentally-regulated Schwann cell surface antigen

scientific article

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis

scientific article published on 24 May 2013

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade

scientific article published on 5 December 2014

The pentapeptide QYNAD does not inhibit neuronal network activity.

scientific article

The prefaces of Charcot: Leitmotifs of an international career ⬇️

scientific article published on October 28, 2003

The role of B cells and autoantibodies in multiple sclerosis

scientific article

The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications ⬇️

scientific article published on July 1, 1997

The role of integrins in immune-mediated diseases of the nervous system

scientific article

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system

scientific article published on March 1990

The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations

scientific article published on October 1988

The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line

scientific article published in April 1988

The role of macrophages in immune-mediated damage to the peripheral nervous system

scientific article

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

scientific article

The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat ⬇️

scientific article published on July 1, 1998

The treatment of multiple sclerosis: current and future.

scientific article published on June 1995

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

scientific article

Therapeutic role of mitoxantrone in multiple sclerosis

scientific article

Therapeutic strategies in the Guillain-Barré syndrome

scientific article

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

scientific article published on 10 May 2010

Tissue mRNA expression in rat of newly described matrix metalloproteinases

scientific article

Toward the development of rational therapies in multiple sclerosis: what is on the horizon?

scientific article published on October 2007

Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous system.

scientific article

Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course

scientific article published on January 1996

Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system

scientific article

Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis

scientific article published on December 1, 1992

Translational research in neurology and neuroscience 2010: multiple sclerosis

scientific article published on 12 July 2010

Treatment and treatment trials in multiple sclerosis

scientific article published on June 2007

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis ⬇️

scientific article published on January 1, 2012

Treatment of chronic inflammatory demyelinating polyradiculoneuropathy

scientific article published on January 2013

Treatment of multiple sclerosis with glatiramer acetate. Current aspects of mechanisms of action, pharmacokinetics, adverse effect profile and clinical studies

scientific article published in April 2002

Treatment of multiple sclerosis: recent trials and future perspectives

scientific article

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness

scientific article published on 11 August 2017

Treatment with ciliary neurotrophic factor does not improve regeneration in experimental autoimmune neuritis of the Lewis rat

scientific article published on 01 September 1996

Troyer syndrome: a combination of central brain abnormality and motor neuron disease?

scientific article

Tuftsin stimulates the release of oxygen radicals and thromboxane from macrophages

scientific article

Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study

scientific article published on September 1, 2010

Usage of Vbeta3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat.

scientific article published on October 1999

Usage of v?3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat

article published in 1999

Vaccination against infection in patients with multiple sclerosis ⬇️

scientific article published on January 24, 2012

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a

scientific article

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

scientific article published on 15 June 2012

Varicella-zoster virus: another trigger of Guillain-Barré syndrome?

scientific article published in September 2010

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of 'Chinese restaurant syndrome'.

scientific article published on 8 April 2016

Vinpocetine inhibits oligodendroglial precursor cell differentiation

scientific article published on August 2012

Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection

scientific article

Visual evoked potentials in neuromyelitis optica and its spectrum disorders

scientific article published on 5 September 2013

Vitamin D as an early predictor of multiple sclerosis activity and progression

scientific article published on March 2014

Volume transmission-mediated encephalopathies: a possible new concept?

scientific article published on March 2012

What Is the Role of Ancillary Investigations in Establishing the Diagnosis of Multiple Sclerosis? ⬇️

scientific article published on January 1, 1997

What do we know about the mechanism of action of disease-modifying treatments in MS?

scientific article

What do we really see when we look at magnetic resonance images?

Word deafness as a cortical auditory processing deficit: a case report with MEG.

scientific article published on 2 September 2008

[Intravenous immunoglobulins in multiple sclerosis. Studies and mechanisms of action--an update]

scientific article published in February 2002

[Intravenous immunoglobulins in therapy of intermittent multiple sclerosis. An update]

scientific article published in April 1998

[Promoting remyelination as a future therapeutic principle in multiple sclerosis?]

scientific article

p57 kip2's role beyond Schwann cell cycle control

scientific article published on 16 September 2008

p57kip2 regulates glial fate decision in adult neural stem cells

scientific article published on 8 August 2012

Paulina is supported by:

About Paulina

Help